NASDAQ:AGIO - Agios Pharmaceuticals, Inc.
$58.86
 $2.73
+4.86%
4:20PM EDT
2019-02-22
Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. The Company's cancer product candidates are enasidenib and ivosidenib (AG-120), which target mutated isocitrate dehydrogenase 2 (IDH2) and isocitrate dehydrogenase 1 (IDH1), respectively, and AG-881, which targets both mutated IDH1 and mutated IDH2. These mutations are found in a range of hematological malignancies and solid tumors. The lead product candidate in its rare genetic metabolic disorder (RGD), programs, AG-348, targets pyruvate kinase-R for the treatment of pyruvate kinase deficiency. Pyruvate kinase deficiency is a rare disorder that often results in severe hemolytic anemia due to inherited mutations in the pyruvate kinase enzyme within red blood cells. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  AGIO     avg for
industry  
  avg for
sector  
42 stocks weight:  95. 11   0. 01   3. 19  
42 stocks rank:  1. 85 K 2. 01 K 1. 09 K
# analyst opinions:  9. 00   14. 84   14. 43  

quick ratio:  8. 00   5. 33   1. 80  
current ratio:  8. 21   5. 64   2. 19  

target price low:  80. 00   89. 87   116. 44  
target price avg:  91. 22   116. 13   140. 62  
target price high:  125. 00   144. 13   161. 60  
1-yr high:  99. 55   124. 91   142. 18  
last close:  54. 08   101. 33   125. 34  
50-day avg:  52. 58   98. 45   122. 34  
200-day avg:  72. 75   99. 87   122. 31  
1-yr low:  42. 73   77. 93   99. 86  
volume:  289. 07 K 2. 40 M 4. 39 M
50-day avg volume:  547. 78 K 3. 29 M 4. 86 M
200-day avg volume:  433. 53 K 3. 21 M 4. 16 M

1-day return:  1. 35 % 0. 35 % -0. 08 %
this week return:  1. 35 % 0. 46 % -0. 07 %
12-wk return:  -15. 82 % 5. 59 % 1. 56 %
52-wk return:  -31. 20 % -0. 88 % 14. 91 %

enterprise value (EV):  2. 43 B 54. 52 B 102. 18 B
market cap:  3. 15 B 48. 30 B 93. 12 B
EBITDA:  -349. 34 M 4. 78 B 7. 07 B
enterprise multiple (EV/EBITDA):  -6. 97   -88. 47   2. 58  
enterprise/revenue (EV/R):  32. 82   30. 50   23. 55  
total revenue:  74. 17 M 11. 17 B 39. 03 B
total debt:  0. 00   13. 63 B 16. 46 B
net income (common):  -342. 52 M 2. 34 B 3. 51 B

shares outstanding:  58. 18 M 601. 87 M 1. 19 B
shares:  50. 88 M 599. 22 M 1. 12 B
shares short:  7. 17 M 11. 51 M 12. 17 M
shares short prior month:  6. 53 M 11. 81 M 13. 15 M
short ratio:  12. 30   4. 63   2. 90  
short % of float:  24. 70 % 6. 17 % 2. 78 %
total cash/share:  11. 51   12. 23   11. 30  
total cash:  669. 89 M 7. 42 B 7. 19 B
free cash flow:  -163. 74 M 94. 45 M 2. 03 B
operating cash flow:  -304. 69 M 161. 90 M 3. 01 B

book value:  13. 07   14. 36   28. 94  
price/book:  4. 14   -1. 54   -2. 98  
gross profits:  -249. 67 M 8. 20 B 15. 98 B
operating margins:  -480. 30 % -468. 22 % -616. 90 %
EBITDA margins:  0. 00 % 13. 04 % 22. 45 %
profit margins:  0. 00 % 6. 01 % 9. 83 %
gross margins:  0. 00 % 48. 26 % 54. 52 %

1-yr max volatility:  -13. 66 % --- ---
1-yr mean volatility:  -0. 06 % 0. 02 % 0. 07 %

1-yr EPS:  -6. 22   2. 91   4. 09  
forward EPS:  -5. 91   4. 19   6. 88  
P/E:  -8. 69   4. 76   27. 05  
forward P/E:  -9. 03   7. 25   10. 02  
PE/G:  -0. 26   1. 60   5. 54  
growth:  33. 80 % 630. 40 % 97. 64 %
earnings high:  -1. 51   1. 24   1. 63  
earnings avg:  -1. 67   0. 98   1. 51  
earnings low:  -1. 85   0. 73   1. 38  
revenue high:  25. 60 M 2. 84 B 10. 79 B
revenue avg:  18. 83 M 2. 75 B 10. 45 B
revenue low:  7. 32 M 2. 64 B 10. 25 B
return on assets:  -27. 55 % -3. 52 % 3. 78 %
return on equity:  -56. 61 % 105. 21 % 25. 65 %
revenue growth:  33. 80 % 595. 46 % 90. 55 %
revenue/share:  1. 35   14. 46   58. 94  

beta (1yr vs S&P500):  1. 03   1. 22   0. 94  
sharpe (1yr):  -0. 30   0. 20   1. 02  

held % insiders:  12. 95 % 6. 52 % 3. 28 %
held % institutions:  99. 74 % 79. 51 % 70. 64 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-11 : AGIO
.    + 1.134 =         1.134 :: INITIAL WEIGHT
.  + 232.986 =       234.119 :: inverse volume-to-price addition
.    + 346.6 =       580.719 :: spline projection addition
.  + 810.675 =      1391.394 :: notable performance addition
.  - 135.354 =       1256.04 :: poor performance penalty
.    x 0.839 =      1053.982 :: one-year gains+dividend factor
.    x 5.072 =      5345.796 :: 13 weeks' performance factor
.    x 1.494 =      7984.425 :: industry recommendation factor
.    x 1.924 =     15360.465 :: EV/R factor
.    x 0.997 =     15318.144 :: return on assets factor
.    x 0.994 =     15231.422 :: return on equity factor
.    x 2.228 =     33940.552 :: revenue growth factor
.    x 2.544 =     86360.387 :: current ratio factor
.    x 1.069 =     92320.665 :: quick ratio factor
.     x 1.04 =     96000.211 :: short ratio factor
.    x 2.041 =    195972.946 :: price-to-book factor
.    x 1.029 =    201682.923 :: 5-day avg > 50-day avg
.    x 2.171 =    437789.408 :: P/E weight
.    x 1.404 =    614727.795 :: PE/G factor
.    x 1.742 =   1070579.332 :: beta factor
.    x 0.304 =    325814.307 :: sharpe factor
.    x 1.742 =    567449.306 :: target low factor
.    x 1.276 =    724199.621 :: target mean factor
.    x 1.115 =    807132.036 :: target high factor
.    x 1.056 =    852242.688 :: industry 12-weeks return
.     x 0.93 =    792458.723 :: "drift" penalty 3 days ago
.      x 1.0 =    792241.825 :: overall "drift" factor
.    x 0.999 =    791794.548 :: largest single-day jump factor
.     x 1.01 =    799707.567 :: mean volatility factor
.    x 1.098 =    877778.643 :: 42-day mean volatility factor
.      x 1.0 =    877829.758 :: factor hist industry gain for week 06
.   cubeRoot =         95.75 :: reduced for readability
.                      95.75 :: FINAL WEIGHT for NASDAQ:AGIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org